Factors influencing hepatocellular carcinoma prognosis after hepatectomy: A single-center experience

Korean Journal of Internal Medicine

Volumn 28, Issue 4, 2013, Pages 428-438

  Park, Sung Keun ^a   Jung, Young Kul ^a   Chung, Dong Hae ^a   Kim, Keon Kuk ^a   Park, Yeon Ho ^a   Lee, Jung Nam ^a   Kwon, Oh Sang ^a   Kim, Yun Soo ^a   Choi, Duck Joo ^a   Kim, Ju Hyun ^a  

^a Gachon University   (South Korea)

Author keywords

Carcinoma; Hepatic resection; Hepatocellular; Prognosis; Vascular invasion

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; BARCELONA CLINIC LIVER CANCER STAGE; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHILD PUGH SCORE; COHORT ANALYSIS; COMORBIDITY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREOPERATIVE EVALUATION; RECURRENT CANCER; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TUMOR INVASION; TUMOR VOLUME; UNION FOR INTERNATIONAL CANCER CONTROL STAGE;

CARCINOMA, HEPATOCELLULAR; HEPATIC RESECTION; PROGNOSIS; VASCULAR INVASION;

ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84880432297     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2013.28.4.428     Document Type: Article

References (28)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001;2:533-543.
2. Ministry of Heath and Welfare. 2008 Annual Report of Cancer Statistics in Korea. Gwacheon: Ministry of Heath and Welfare, 2010.
3. Ministry of Heath and Welfare. Cancer Incidence in Korea 1999-2001. Gwacheon: Ministry of Heath and Welfare, 2005.
4. Park JW, Kim CM. Epidemiology of hepatocellular carcinoma in Korea. Korean J Hepatol 2005;11:303-310.
5. Sharma P, Balan V, Hernandez JL, et al. Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl 2004;10:36-41.
6. Lee KU, Koh YT, Kim KH, et al. Prognostic factors of hepatocellular carcinoma after curative hepatic resection. Korean J Hepatobiliary Pancreat Surg 1997;1:41-58.
7. Poon RT, Fan ST, Lo CM, et al. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 2001;234:63-70.
8. Minagawa M, Makuuchi M, Takayama T, Kokudo N. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg 2003;238:703-710.
9. Ueno S, Tanabe G, Nuruki K, et al. Prognostic performance of the new classification of primary liver cancer of Japan (4th edition) for patients with hepatocellular carcinoma: a validation analysis. Hepatol Res 2002;24:395-403.
10. Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-1236.
11. Gouw AS, Balabaud C, Kusano H, Todo S, Ichida T, Kojiro M. Markers for microvascular invasion in hepatocellular carcinoma: where do we stand? Liver Transpl 2011;17 Suppl 2:S72-S80.
12. Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004;130:417-422.
13. Shah SA, Cleary SP, Wei AC, et al. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes. Surgery 2007;141:330-339.
14. Kim SH, Choi SB, Lee JG, et al. Prognostic factors and 10-year survival in patients with hepatocellular carcinoma after curative hepatectomy. J Gastrointest Surg 2011;15:598-607.
15. Song TJ, Ip EW, Fong Y. Hepatocellular carcinoma: current surgical management. Gastroenterology 2004;127(5 Suppl 1):S248-S260.
16. Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999;229:790-799.
17. Chen YL, Ko CJ, Chien SY, et al. Tumor size as a prognostic factor in resected small hepatocellular carcinoma: a controversy revisited. J Gastroenterol Hepatol 2011;26:851-857.
18. Calvet X, Bruix J, Gines P, et al. Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients. Hepatology 1990;12(4 Pt 1):753-760.
19. Song IH, Kim KS. Current status of liver diseases in Korea: hepatocellular carcinoma. Korean J Hepatol 2009;15 Suppl 6:S50-S59.
20. Oh KC, Park SH, Park JC, et al. Is the prevalence of cryptogenic hepatocellular carcinoma increasing in Korea? Korean J Gastroenterol 2005;45:45-51.
21. Makuuchi M, Sano K. The surgical approach to HCC: our progress and results in Japan. Liver Transpl 2004;10:S46-S52.
22. Korean Liver Cancer Study Group; National Cancer Center, Korea. Practice guidelines for management of hepatocellular carcinoma 2009. Korean J Hepatol 2009;15:391-423.
23. Vitale A, Saracino E, Boccagni P, et al. Validation of the BCLC prognostic system in surgical hepatocellular cancer patients. Transplant Proc 2009;41:1260-1263.
24. Okuda K, Nakashima T, Obata H, Kubo Y. Clinicopathological studies of minute hepatocellular carcinoma: analysis of 20 cases, including 4 with hepatic resection. Gastroenterology 1977;73:109-115.
25. Minagawa M, Ikai I, Matsuyama Y, Yamaoka Y, Makuuchi M. Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg 2007;245:909-922.
26. Vauthey JN, Lauwers GY, Esnaola NF, et al. Simplified staging for hepatocellular carcinoma. J Clin Oncol 2002;20:1527-1536.
27. Jonas S, Bechstein WO, Steinmuller T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001;33:1080-1086.
28. Lim KC, Chow PK, Allen JC, et al. Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria. Ann Surg 2011;254:108-113.